US Patent Issued to Roche Diagnostics Operations on July 15 for "Biotin-specific monoclonal antibody and use thereof" (German Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,360,108, issued on July 15, was assigned to Roche Diagnostics Operations Inc..

"Biotin-specific monoclonal antibody and use thereof" was invented by Michael Gerg (Munich), Klaus Hirzel (Baierbrunn, Germany), Caroline Hojer (Munich), Erasmus Huber (Finning, Germany), Hans-Peter Josel (Weilheim, Germany), Thomas Meier (Munich), Michael Schraeml (Penzberg, Germany) and Leopold Von Proff (Hohenpeissenberg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a monoclonal antibody capable of binding to biotin. In one embodiment the monoclonal antibody according to the invention also does not bind to a biotin moiety on a bio...